Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
To assess the histological grade in benign and malignant cartilage tumors of bone by more objective methods, we examined the differentiation and proliferative activity of tumor cells in six enchondromas, five chondroblastomas, and 13 chondrosarcomas immunohistochemically. A variable number of cells in all tumors showed S-100 protein and vimentin immunoreactivity. In fully differentiated cartilage of enchondromas and low grade chondrosarcomas, tenascin, which is an extracellular matrix glycoprotein, was present in small amounts or absent but was increased at the periphery of tumor lobules and even in the matrix throughout the high grade chondrosarcomas. Higher rate and intensity of proliferating cell nuclear antigen (PCNA) reactivity were found in chondrosarcomas, especially in spindle-shaped cells of high grade tumors, than in enchondromas. The distribution of PCNA-positive cells almost corresponded to the regions with tenascin reactivity. One tumor of high grade chondrosarcoma showed p53 protein immunoreactivity. Aberrant expression of cytokeratin was observed in four chondroblastomas. The expression of desmin was identified in relatively large proportions of enchondromas and chondrosarcomas, regardless of their benign or malignant nature and histological grade. Smooth muscle or muscle-specific actins also were present in a smaller number of tumors. Based on these findings, it is concluded that unusual staining characteristics were present, in addition to those of a chondroblastic nature, in the cartilage tumors of bone. Tenascin and PCNA positivity of various degrees in all chondroblastomas may suggest that they are chondrogenic tumors having a relatively high proliferative activity, albeit their benign clinical course. Proliferative activity of tumor cells in enchondromas and chondrosarcomas correlated well with their histological grade. Tenascin may play a role in promoting tumor cell proliferation of cartilagenous neoplasms and, on the other hand, the alterations of extracellular matrix involving tenascin synthesis seem to be a result of tumor development.
Hasegawa
T
T
First Department of Pathology, University of Tokushima School of Medicine, Japan.
Seki
K
K
Yang
P
P
Hirose
T
T
Hizawa
K
K
Wada
T
T
Wakabayashi
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000737:chemistry* / Q000473:pathology; D015816:Cell Adhesion Molecules, Neuronal / Q000032:analysis; D002455:Cell Division / Q000502:physiology; D002471:Cell Transformation, Neoplastic / Q000737:chemistry / Q000473:pathology; D002648:Child; D002804:Chondroblastoma / Q000737:chemistry* / Q000473:pathology; D002812:Chondroma / Q000737:chemistry* / Q000473:pathology; D002813:Chondrosarcoma / Q000737:chemistry* / Q000473:pathology; D003598:Cytoskeletal Proteins / Q000032:analysis; D016326:Extracellular Matrix Proteins / Q000032:analysis; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis*; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D009418:S100 Proteins / Q000032:analysis; D019063:Tenascin; D016159:Tumor Suppressor Protein p53 / Q000032:analysis
D015816:Cell Adhesion Molecules, Neuronal; D003598:Cytoskeletal Proteins; D016326:Extracellular Matrix Proteins; D009363:Neoplasm Proteins; D018809:Proliferating Cell Nuclear Antigen; D009418:S100 Proteins; D019063:Tenascin; D016159:Tumor Suppressor Protein p53